Robert Papp - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Robert Papp

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Nature|April 21, 2022

CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibitionDavid Gallo, Jordan T F Young, Jimmy Fourtounis, et al.

Journal of Medicinal Chemistry|May 16, 2025

Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 InhibitorFrédéric Vallée, Matias Casás-Selves, Monica Bubenik, et al.

Journal of Medicinal Chemistry|September 8, 2025

The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase InhibitorPhilippe Mochirian, Robert Papp, Marie-Claude Mathieu, et al.

Journal of Medicinal Chemistry|September 20, 2022

Identification of <b>RP-6685</b>, an Orally Bioavailable Compound that Inhibits the DNA Polymerase Activity of PolθMonica Bubenik, Pavel Mader, Philippe Mochirian, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Nature|April 21, 2022

CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibitionDavid Gallo, Jordan T F Young, Jimmy Fourtounis, et al.

Journal of Medicinal Chemistry|May 16, 2025

Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 InhibitorFrédéric Vallée, Matias Casás-Selves, Monica Bubenik, et al.

Journal of Medicinal Chemistry|September 8, 2025

The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase InhibitorPhilippe Mochirian, Robert Papp, Marie-Claude Mathieu, et al.

Journal of Medicinal Chemistry|September 20, 2022

Identification of <b>RP-6685</b>, an Orally Bioavailable Compound that Inhibits the DNA Polymerase Activity of PolθMonica Bubenik, Pavel Mader, Philippe Mochirian, et al.

Pageof 3